KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 112 filers reported holding KYMERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,090,945 | -37.6% | 366,255 | +3.2% | 0.00% | -50.0% |
Q2 2023 | $8,159,795 | -18.2% | 354,928 | +5.4% | 0.00% | 0.0% |
Q1 2023 | $9,980,184 | +17.1% | 336,827 | -1.4% | 0.00% | 0.0% |
Q4 2022 | $8,522,367 | +18.0% | 341,441 | +2.9% | 0.00% | 0.0% |
Q3 2022 | $7,221,000 | +10.0% | 331,738 | -0.5% | 0.00% | +100.0% |
Q2 2022 | $6,564,000 | -51.5% | 333,378 | +4.2% | 0.00% | -50.0% |
Q1 2022 | $13,536,000 | -37.1% | 319,870 | -5.6% | 0.00% | -50.0% |
Q4 2021 | $21,516,000 | +8.1% | 338,900 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $19,897,000 | +58.1% | 338,723 | +30.5% | 0.00% | +100.0% |
Q2 2021 | $12,587,000 | +175.7% | 259,515 | +120.9% | 0.00% | +100.0% |
Q1 2021 | $4,566,000 | -39.6% | 117,501 | -3.6% | 0.00% | 0.0% |
Q4 2020 | $7,559,000 | – | 121,926 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
AtonRa Partners | 34,462 | $750,000 | 0.74% |
Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |